Target intelligence / Profile preview

Bacterial motility and biofilm formation machinery

Molecular classification
Multi-protein complex, Signaling system, Cell surface assembly, Enzyme
01

Overview

Bacterial motility and biofilm formation machinery refers to the integrated systems of appendages, signaling molecules, and extracellular components that allow bacteria to navigate environments and establish resilient communities (Kearns, 2010; Römling et al., 2013). Motility is often driven by flagella or pili, which are essential for the initial stages of surface colonization and host tissue invasion (Hall-Stoodley et al., 2004). Once attached, bacteria utilize quorum sensing and secondary messengers like cyclic-di-GMP to transition into a biofilm state, characterized by the production of a protective extracellular polymeric substance (EPS) matrix (Flemming & Wingender, 2010). This matrix acts as a physical barrier, contributing significantly to the high levels of antibiotic tolerance and immune evasion observed in chronic infections such as cystic fibrosis and catheter-associated urinary tract infections (Kostakioti et al., 2013). Therapeutic targeting of these processes, known as anti-virulence strategies, aims to disarm the bacteria by inhibiting adhesion, disrupting cell-to-cell communication, or promoting biofilm dispersal, thereby making the pathogens more susceptible to the host immune response and conventional antimicrobial agents (Dickey et al., 2017).

Other names
Bacterial biofilm apparatusMotility and adhesion machineryQuorum sensing and biofilm regulatory networkSurface attachment systems
02

Mechanism of action

Anti-virulence mechanisms including competitive antagonism of adhesins (e.g., FimH), disruption of iron-dependent biofilm development, inhibition of quorum sensing receptors (e.g., LasR), and enzymatic degradation of the extracellular matrix.

03

Biological functions

Cell motilityAdhesionBiofilm formationQuorum sensingExtracellular matrix productionSignal transduction
04

Disease associations

InfectionCystic fibrosisUrinary tract infectionChronic wound infectionMedical device-associated infectionEndocarditis
05

Safety considerations

Disruption of commensal microbiotaLimited penetration into mature biofilmsPotential for compensatory bacterial adaptationsRisk of horizontal gene transfer during dispersal
06

Interacting drugs

Sibofimloc

5 more in the full profile.

07

Biomarkers

Cyclic-di-GMPAlginateExtracellular DNA (eDNA)Autoinducer-2 (AI-2)

Beyond the preview

Go deeper on Bacterial motility and biofilm formation machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial motility and biofilm formation machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call